A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
pubmed:
22
11
2022
medline:
15
12
2022
entrez:
21
11
2022
Statut:
ppublish
Résumé
New pediatric and adult subacute sclerosing panencephalitis cases between 1996 and 2020 were reported based on an established UK registry with no evidence of under-ascertainment using a separate pediatric surveillance system. After 15 years with no pediatric UK-acquired cases, 3 cases arose from 2017 after increased measles. Modeling suggested this was in line with measles notifications, underreporting of laboratory-confirmed measles or increased subacute sclerosing panencephalitis risk.
Identifiants
pubmed: 36410008
doi: 10.1097/INF.0000000000003744
pii: 00006454-202301000-00021
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
82-84Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Campbell H, Andrews N, Brown KE, et al. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334–1348.
European Centre for Disease Prevention and Control. Risk assessment: who is at risk of measles in the EU/EAA? May 28, 2019. Available at: ( europa.eu ). Accessed September 18, 2022.
Miller C, Andrews N, Rush M, et al. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990–2002. Arch Dis Child. 2004;89:1145–1148.
Schonberger K, Ludwig M-S, Wildner M, et al. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One. 2013;8:e689091–e689098.
Wendorf KA, Winter K, Zipprich J, et al. Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated. Clin Infect Dis. 2017;65:226–232.
World Health Organization Regional Office for Europe. Conclusions of the 8th meeting of the European regional verification commission for measles and rubella elimination (RVC). 2019. Available at: https://www.who.int/europe/publications/i/item/WHO-EURO-2019-3623-43382-60860 . Accessed October 3, 2022.
3b. ECDC. Communicable disease threats report. Week 28. July 5–11, 2020. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Communicable-disease-threats-report-11-july-2020.pdf . Accessed October 3, 2022.
World Health Organization. Immunization analysis and insights: provional monthly measles and rubella data. Immunization Analysis and Insights. Available at: ( who.int ). Accessed August 24, 2022.
Verity C, Winstone AM, Stellitano L, et al. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child. 2010;95:361–364.
Lam T, Ranjan R, Newark K, et al. A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: an emergence in a time of measles. Eur J Paediatr Neurol. 2021;34:43–49.
Griffin DE. Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol. 2010;91:95–101.
Kweder H, Ainouze M, Brunel J, et al. Measles virus: identification in the M protein primary sequence of a potential molecular marker for subacute sclerosing panencephalitis. Adv Virol. 2015;2015:769837.